Clinical trial

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

NCT03907423

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-01

PhaseNA

Study timeline

Study start (actual)2019-04-01Date precision: day

Registry last updated2023-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Rosuvastatin10 mg tabletDRUG

Placebo Oral TabletDRUG

Sponsors & collaborators

Rehab Weridalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03907423 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.